Randomized Controlled Trial on the Use of EPO to Reduce Top-up Transfusions in Neonates With Red Blood Cell Alloimmunization Treated With Intrauterine Transfusions

Trial Profile

Randomized Controlled Trial on the Use of EPO to Reduce Top-up Transfusions in Neonates With Red Blood Cell Alloimmunization Treated With Intrauterine Transfusions

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 21 Nov 2017

At a glance

  • Drugs Darbepoetin alfa (Primary)
  • Indications Anaemia; Haemolytic disease of newborn
  • Focus Therapeutic Use
  • Acronyms EPO-4-Rhesus Study
  • Most Recent Events

    • 14 Nov 2017 Status changed from not yet recruiting to recruiting.
    • 17 Oct 2017 Planned initiation date changed from 1 Sep 2017 to 1 Nov 2017.
    • 09 Aug 2017 Planned initiation date changed from 1 Jun 2017 to 1 Sep 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top